Viewing Study NCT04432857


Ignite Creation Date: 2025-12-24 @ 6:55 PM
Ignite Modification Date: 2025-12-30 @ 1:24 AM
Study NCT ID: NCT04432857
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-06-27
First Post: 2020-06-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: AN0025 and Pembrolizumab Combination in Advanced Solid Tumors
Sponsor: Adlai Nortye Biopharma Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Annotation Module